Press Releases

Date Title View
Toggle Summary Second Sight to Present at 18th Annual B. Riley & Co. Institutional Investor Conference
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to provide some useful vision to blind patients, today announced that Will McGuire , President and Chief
View HTML
Toggle Summary Second Sight Reports First Quarter 2017 Financial Results
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three-months
View HTML
Toggle Summary Second Sight to Discuss First Quarter 2017 Financial Results on May 3, 2017 Conference Call
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to provide some useful vision to blind patients, will release its first quarter financial results on Wednesday, May 3,
View HTML
Toggle Summary Second Sight's Argus II Retinal Prosthesis Implanted in First Patient in Asia
--Underscores Second Sight's Commitment to Expansion in Asia -- SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to provide some useful
View HTML
Toggle Summary Second Sight Announces Dr. Robert Greenberg, Chairman, Inducted as a National Academy of Inventors Fellow
-Highest Professional Distinction Accorded to Inventors Demonstrating a Prolific Spirit of Innovation- SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES), ("Second Sight" or the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics
View HTML
Toggle Summary Second Sight Medical Products, Inc. Announces Warrants Approved for Listing on Nasdaq With Trading Scheduled to Commence March 29 under Symbol "EYESW"
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES), (the "Company"), a developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, today announced that warrants issued in connection with its recent
View HTML
Toggle Summary Second Sight Reports Fourth Quarter and Year End 2016 Financial Results
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three- and
View HTML
Toggle Summary Second Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights Offering
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, today announced that it has completed its previously
View HTML
Toggle Summary Second Sight Appoints David Jacques as Vice President of Research and Development
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that provide some useful vision to blind patients, today announced the appointment of David Jacques as
View HTML
Toggle Summary Second Sight to Discuss Fourth Quarter and Year-End 2016 Financial Results on March 9, 2017 Conference Call
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its fourth quarter and year-end financial results on Thursday, March 9, 2017
View HTML